Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Rockwall › NPI 1629138029
Hospital

Rockwall Regional Hospital, LLC

Rockwall Regional Hospital, LLC was paid $976K by Medicaid between Jan 2020 and Nov 2024, across 47 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.

33Billing provider infoROCKWALL REGIONAL HOSPITAL, LLC
ROCKWALL, TX 75032
33aNPI1629138029assigned 12/08/2006
28Total paid$976K
24GClaims24,881
24DCodes billed47
24AFirst – last monthJan 2020 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in Texas

Rank by total paid#58 of 109
Median peer was paid$1.15M
This provider vs. median0.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020334$2K
20216,037$266K
202210,250$356K
20235,708$262K
2024incomplete2,552$90K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 38% 2,230 2,089 $367K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 2,919 2,786 $167K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 15% 632 583 $151K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 8.8% 1,044 1,010 $86K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.9% 855 822 $29K
80053 Comprehensive metabolic panel 2.5% 2,325 2,019 $24K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.5% 977 876 $24K
71045 Radiologic examination, chest; single view 2.2% 1,008 926 $21K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.0% 2,960 2,436 $19K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.8% 77 73 $18K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.7% 1,358 1,313 $16K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.1% 355 339 $10K
35 more codes
84484 <1% 868 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 77 $4K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 60 $3K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 561 $3K
70450 Computed tomography, head or brain; without contrast material <1% 52 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 400 $2K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 42 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 609 $2K
87634 <1% 44 $2K
81025 <1% 316 $2K
81001 <1% 951 $2K
83880 <1% 106 $2K
83690 <1% 492 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 242 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 28 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 59 $967.68
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 13 $827.09
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 14 $696.85
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 562 $463.63
84703 <1% 64 $449.16
80048 Basic metabolic panel (calcium, ionized) <1% 86 $415.30
J2270 Injection, morphine sulfate, up to 10 mg <1% 249 $348.92
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 50 $318.11
83605 <1% 58 $270.83
81003 <1% 155 $248.72
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 145 $189.75
96361 Intravenous infusion, hydration; each additional hour <1% 51 $182.84
84702 <1% 15 $113.76
83735 <1% 26 $85.90
36415 Collection of venous blood by venipuncture <1% 1,338 $82.48
85379 <1% 13 $54.20
87086 Culture, bacterial; quantitative colony count, urine <1% 24 $46.70
85610 <1% 16 $18.67
86901 <1% 14 $15.06
A9270 Non-covered item or service 0% 341 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLINSCOTT, JASON (PRESIDENT)